Open Government Canada
Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19)
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Amendment is to notify about the addition of casirivimab and imdevimab to the Prescription Drug List (PDL) for human and veterinary use.